The LSE Companion to Health Policy covers a wide range of conceptual and practical issues from a number of different perspectives introducing the reader to, and summarising, the vast literature that analyzes the complexities of health policy. The Companion also assesses the current state of the art. Health policy is a wide-ranging subject covering many academic disciplines, but what most studies in health policy have in common is an interest in applying theory to improve practice. This Companion brings academic rigor to bear evidence on a range of central areas within health policy. It covers key issues on the quality, access and inequalities in health and health care; supply and health markets; insurance and expenditures; pharmaceuticals and new technologies; ageing and long-term care; and behavior and health production. This unique Companion on health policy contains the most important features for health system reform at a time of funding constraints and will therefore hold great appeal for policy analysts and makers, students, academics and management professionals. Contributors: S. Allin, R.G. Bevan, R. Butterfield, C. Campbell, A. Comas-Herrera, Z. Cooper, J. Costa-Font, M. Di Cesare, H.A. Elgazzar, J.-L. Fernandez, A. Gibbs, C. Henderson, C. Hernandez-Quevedo, L. Kossarova, C. Masseria, A. McGuire, P. Mladovsky, A. Morton, M. Murphy, I. Papanicolas, M. Raikou, C. Rudisill, V. Serra-Sastre, C. Stavropoulou, N. Varol, J.M. Wiener, R. Wittenberg, V. Zigante

To accompany the hugely successful 'Methods for Economic Evalution of Health Care Programmes 2 e', this book is a thorough and rigorous discussion of the methodological principles and recent advances in the rapidly advancing field of theory and practice of economic evaluation in health care. Written by an internationally acclaimed group of authors, the book provides an in-depth discussion of the latest theoretical advances and gives comprehensive reviews of the available literature. The book covers the main areas of economic evaluation, including the methods for measuring costs and outcomes, the collection of data alongside clinical studies, ways of handling uncertainty, discounting and issues relating to the transferability of ecoonomic data.

It is an ideal book for those studying economic evaluation on postgraduate or professional courses in health economics or public health.

The LSE Companion to Health Policy covers a wide range of conceptual and practical issues from a number of different perspectives introducing the reader to, and summarising, the vast literature that analyzes the complexities of health policy. The Companion also assesses the current state of the art. Health policy is a wide-ranging subject covering many academic disciplines, but what most studies in health policy have in common is an interest in applying theory to improve practice. This Companion brings academic rigor to bear evidence on a range of central areas within health policy. It covers key issues on the quality, access and inequalities in health and health care; supply and health markets; insurance and expenditures; pharmaceuticals and new technologies; ageing and long-term care; and behavior and health production. This unique Companion on health policy contains the most important features for health system reform at a time of funding constraints and will therefore hold great appeal for policy analysts and makers, students, academics and management professionals. Contributors: S. Allin, R.G. Bevan, R. Butterfield, C. Campbell, A. Comas-Herrera, Z. Cooper, J. Costa-Font, M. Di Cesare, H.A. Elgazzar, J.-L. Fernandez, A. Gibbs, C. Henderson, C. Hernandez-Quevedo, L. Kossarova, C. Masseria, A. McGuire, P. Mladovsky, A. Morton, M. Murphy, I. Papanicolas, M. Raikou, C. Rudisill, V. Serra-Sastre, C. Stavropoulou, N. Varol, J.M. Wiener, R. Wittenberg, V. Zigante

Technological change in healthcare has led to huge improvements in health services and the health status of populations. It is also pinpointed as the main driver of healthcare expenditure. Although offering remarkable benefits, changes in technology are not free and often entail significant financial, as well as physical or social risks. These need to be balanced out in the setting of government regulations, insurance contracts, and individual's decisions to use and consume certain technologies. With this in mind, this book addresses the following important objectives: to provide a detailed analysis of what technological change is; to identify drivers of innovation in several healthcare areas; to present existing mechanisms and processes for ensuring and valuing efficiency and development in the use of medical technologies; and to analyze the impact of advances in medical technology on health, healthcare expenditure, and health insurance.
Each of the seventeen chapters summarizes an important issue concerning the innovation debate and contributes to a better understanding of the role innovation has both at the macro level and at the delivery (meso) and micro level in the healthcare sector. The effectiveness of innovation in improving people's welfare depends on its diffusion and inception by the relevant agents in the health production process, and this book recognizes the multi-faceted contribution of policy makers, regulators, managers, technicians, consumers and patients to this technology.
This book offers the first truly global economic analysis of healthcare technologies, taking the subject beyond simply economic evaluation and exploring the behavioral aspects, organization and incentives for new technology developments, and the adoption and diffusion of these technologies.

To accompany the hugely sccessful 'Methods for Economic Evaluation of Health Care Programmes 2e', this book is a thorough and rigorous discussion of the methodological principles and recent advances in the rapidly advancing field of theory and practice of economic evaluation in health care. Written by an internationally acclaimed group of authors, the book provides an in-depth discussion of the latest theoretical advances and gives comprehensive reviews of the available literature. The book covers the main areas of economic evaluation, including the methods for measuring costs and outcomes, the collection of data alongside clinical studies, ways of handling uncertainty, discounting and issues relating to the transferability of economic data.